These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2066381)

  • 1. A role for osteocalcin in osteoclast differentiation.
    Glowacki J; Rey C; Glimcher MJ; Cox KA; Lian J
    J Cell Biochem; 1991 Mar; 45(3):292-302. PubMed ID: 2066381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate.
    Glowacki J; Jasty M; Goldring S
    J Bone Miner Res; 1986 Aug; 1(4):327-31. PubMed ID: 3503546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocalcin promotes differentiation of osteoclast progenitors from murine long-term bone marrow cultures.
    Liggett WH; Lian JB; Greenberger JS; Glowacki J
    J Cell Biochem; 1994 Jun; 55(2):190-9. PubMed ID: 8089194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of subcutaneous implants of bone particles from normal and warfarin-treated rats.
    Serre CM; Price P; Delmas PD
    J Bone Miner Res; 1995 Aug; 10(8):1158-67. PubMed ID: 8585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats.
    Defranco DJ; Lian JB; Glowacki J
    Endocrinology; 1992 Jul; 131(1):114-21. PubMed ID: 1611989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of an osteoclast antigen and ruffled border on giant cells formed in response to resorbable substrates.
    Webber D; Osdoby P; Hauschka P; Krukowski M
    J Bone Miner Res; 1990 Apr; 5(4):401-10. PubMed ID: 2343780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1 alpha,25-dihydroxyvitamin D3 have ruffled borders and resorb dentine.
    Sasaki T; Takahashi N; Higashi S; Suda T
    Anat Rec; 1989 Jul; 224(3):379-91. PubMed ID: 2782622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bone matrix components on osteoclast differentiation.
    Glowacki J; Rey C; Cox K; Lian J
    Connect Tissue Res; 1989; 20(1-4):121-9. PubMed ID: 2692953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tartrate-resistant acid phosphatase activity in tibial osteoclasts and cells elicited by ectopic bone and suture implants in normal and osteopetrotic rats.
    Walters LM; Schneider GB
    Bone Miner; 1988 Apr; 4(1):49-62. PubMed ID: 3056541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinucleated cells elicited in response to implants of devitalized bone particles possess receptors for calcitonin.
    Goldring SR; Roelke M; Glowacki J
    J Bone Miner Res; 1988 Feb; 3(1):117-20. PubMed ID: 2850723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation and function of osteoclasts cultured on bone and cartilage.
    Suzumoto R; Takami M; Sasaki T
    J Electron Microsc (Tokyo); 2005 Dec; 54(6):529-40. PubMed ID: 16510510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants.
    Glowacki J; Lian JB
    Cell Differ; 1987 Sep; 21(4):247-54. PubMed ID: 3304665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of the giant cell infiltrate of subcutaneously implanted bone particles in rats and mice.
    Popoff SN; Marks SC
    Am J Anat; 1986 Dec; 177(4):491-503. PubMed ID: 3544796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
    Hollberg K; Marsell R; NorgÄrd M; Larsson T; Jonsson KB; Andersson G
    Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
    Huang J; Yuan L; Wang X; Zhang TL; Wang K
    Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo.
    DeFranco DJ; Glowacki J; Cox KA; Lian JB
    Calcif Tissue Int; 1991 Jul; 49(1):43-50. PubMed ID: 1893294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
    Quinn JM; McGee JO; Athanasou NA
    J Pathol; 1998 Jan; 184(1):31-6. PubMed ID: 9582524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.